Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
Article excerpt
Highlighted: the sentence this signal was extracted from
New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Mass., Oct. 7, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating officer (COO), effective Jan. 1, 2027. In this role, Fitzgerald will oversee the company's global operations, business units and regions. In connection with Fitzgerald's appointment, Boston Scientific will establish three reportable segments* - Interventional Therapies, Rhythm Solutions and MedSurg also effective Jan. 1. As the company continues to grow and expand its portfolio, the structure is designed to enable faster decision making and support strategic allocation of investments across the company's portfolio. "Joe's deep knowledge of our business and markets, strategic leadership and strong track record of execution make him well suited for this role," said Mike Mahoney, chairman and chief executive officer, Boston Scientific. "These changes reflect the scale and breadth of our business today and the opportunities ahead. The new operating model will create greater capacity to focus on our long-term growth priorities while enabling our businesses to move faster and remain close to our customers and their patients." Lance Bates, executive vice president and president, Interventional Therapies...
Keep reading with a free account
The rest of this article, and every signal for Boston Scientific, is in your free account.
